Recent updates on mechanisms of resistance to 5-fluorouracil and reversal strategies in colon cancer treatment

S Azwar, HF Seow, M Abdullah, M Faisal Jabar… - Biology, 2021 - mdpi.com
Simple Summary Acquired resistance to chemotherapy by cancer cells is the predominant
factor in chemotherapy failure, which ultimately leads to disease progression and death …

Advances in translational research of the rare cancer type adrenocortical carcinoma

C Ghosh, J Hu, E Kebebew - Nature Reviews Cancer, 2023 - nature.com
Adrenocortical carcinoma is a rare malignancy with an annual worldwide incidence of 1–2
cases per 1 million and a 5-year survival rate of< 60%. Although adrenocortical carcinoma is …

Apoptotic extracellular vesicles ameliorate multiple myeloma by restoring fas-mediated apoptosis

J Wang, Z Cao, P Wang, X Zhang, J Tang, Y He… - ACS …, 2021 - ACS Publications
Apoptosis is critical for maintaining bodily homeostasis and produces a large number of
apoptotic extracellular vesicles (apoEVs). Several types of cancer cells display reduced …

Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo

ZY Al Subeh, DB Poschel, PS Redd, JD Klement… - ACS …, 2022 - ACS Publications
Fas ligand (FasL), expressed on the surface of activated cytotoxic T lymphocytes (CTLs), is
the physiological ligand for the cell surface death receptor, Fas. The Fas-FasL engagement …

Perspectives on immunotherapy of metastatic colorectal cancer

Y Dai, W Zhao, L Yue, X Dai, D Rong, F Wu, J Gu… - Frontiers in …, 2021 - frontiersin.org
Colorectal cancer, especially liver metastasis, is still a challenge worldwide. Traditional
treatment such as surgery, chemotherapy and radiotherapy have been difficult to be further …

[HTML][HTML] Immunotherapy with immune checkpoint inhibitors for advanced colorectal cancer: a promising individualized treatment strategy

Y Yang, WJ Meng, ZQ Wang - Frontiers in Bioscience-Landmark, 2023 - imrpress.com
Colorectal cancer (CRC) is one of the high incident and lethal malignant tumors, and most of
the patients are diagnosed at an advanced stage. The treatment of CRC mainly includes …

Tumor microenvironment in adrenocortical carcinoma: barrier to immunotherapy success?

N Georgantzoglou, S Kokkali, G Tsourouflis… - Cancers, 2021 - mdpi.com
Simple Summary Adrenocortical carcinoma is a rare but aggressive malignancy with poor
outcomes even for patients with early-stage disease. Several immunotherapy clinical trials …

SRSF6 regulates the alternative splicing of the apoptotic fas gene by targeting a novel RNA sequence

N Choi, HN Jang, J Oh, J Ha, H Park, X Zheng, S Lee… - Cancers, 2022 - mdpi.com
Simple Summary Alternative splicing (AS) produces multiple mRNA isoforms from a gene to
make a large number of proteins. Fas (Apo-1/CD95) pre-mRNA, a member of TNF receptor …

CD95L and anti-tumor immune response: current understanding and new evidence

DM Richards, C Merz, C Gieffers… - Cancer management …, 2021 - Taylor & Francis
The ability of FasL/CD95L to induce apoptosis in various Fas/CD95-expressing cells has
been described in the context of hematopoiesis or thymic elimination of self-reactive T cells …

[HTML][HTML] Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine …

L Carlsen, C Schorl, K Huntington… - Oncotarget, 2021 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) caused over 900,000 deaths worldwide in 2020. A majority of late-
stage CRC patients are treated with 5-fluorouracil (5-FU) combined with either irinotecan …